标题
Protein engineering to target complement evasion in cancer
作者
关键词
-
出版物
FEBS LETTERS
Volume 588, Issue 2, Pages 334-340
出版商
Wiley
发表日期
2013-11-14
DOI
10.1016/j.febslet.2013.11.007
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Functional Anatomy of Complement Factor H
- (2013) Elisavet Makou et al. BIOCHEMISTRY
- Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites
- (2013) I. Bally et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Humoral Pattern Recognition and the Complement System
- (2013) S. E. Degn et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Characterization of novel CD55 isoforms expression in normal and neoplastic tissues
- (2013) E. D. Vainer et al. TISSUE ANTIGENS
- Structural Basis for Recognition of the Pore-Forming Toxin Intermedilysin by Human Complement Receptor CD59
- (2013) Steven Johnson et al. Cell Reports
- Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity
- (2012) Lin Wu et al. CURRENT PHARMACEUTICAL DESIGN
- Regulation of Humoral Immunity by Complement
- (2012) Michael C. Carroll et al. IMMUNITY
- HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas
- (2012) Federica Guzzo et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Arranged Sevenfold: Structural Insights into the C-Terminal Oligomerization Domain of Human C4b-Binding Protein
- (2012) Thomas Hofmeyer et al. JOURNAL OF MOLECULAR BIOLOGY
- Transient Removal of CD46 Is Safe and Increases B-cell Depletion by Rituximab in CD46 Transgenic Mice and Macaques
- (2012) Ines Beyer et al. MOLECULAR THERAPY
- Complement in health and disease
- (2011) Maria V. Carroll et al. ADVANCED DRUG DELIVERY REVIEWS
- Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for Treatment of Refractory Chronic Lymphocytic Leukemia
- (2011) Ginah Nightingale ANNALS OF PHARMACOTHERAPY
- Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis
- (2011) W. Hu et al. CANCER RESEARCH
- Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor
- (2011) Emiliano Cocco et al. CLINICAL & EXPERIMENTAL METASTASIS
- Trastuzumab Treatment in Multiple Lines: Current Data and Future Directions
- (2011) M. Pegram et al. Clinical Breast Cancer
- rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia
- (2011) X. Ge et al. CLINICAL CANCER RESEARCH
- Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis
- (2011) Laurent Mesnard et al. FASEB JOURNAL
- CD46 processing: A means of expression
- (2011) Siobhan Ni Choileain et al. IMMUNOBIOLOGY
- Complement factor I in health and disease
- (2011) Sara C. Nilsson et al. MOLECULAR IMMUNOLOGY
- C1-Inhibitor: More Than a Serine Protease Inhibitor
- (2011) Sacha Zeerleder SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro
- (2010) N. Geis et al. CURRENT CANCER DRUG TARGETS
- Jmol– a paradigm shift in crystallographic visualization
- (2010) Robert M. Hanson JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Ofatumumab
- (2010) Bodi Zhang mAbs
- Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions
- (2010) Gregory L. Moore et al. mAbs
- Role and mechanism of action of complement in regulating T cell immunity
- (2010) Jason R. Dunkelberger et al. MOLECULAR IMMUNOLOGY
- Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells
- (2010) John Cardone et al. NATURE IMMUNOLOGY
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy
- (2009) H. Wang et al. BLOOD
- Complement and its role in innate and adaptive immune responses
- (2009) Jason R Dunkelberger et al. CELL RESEARCH
- Optimization of Fc-mediated effector functions of monoclonal antibodies
- (2009) William R Strohl CURRENT OPINION IN BIOTECHNOLOGY
- The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35)
- (2009) Dong Liu et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- A High-Affinity Inhibitor of Human CD59 Enhances Complement-Mediated Virolysis of HIV-1: Implications for Treatment of HIV-1/AIDS
- (2009) Weiguo Hu et al. JOURNAL OF IMMUNOLOGY
- CD59 Blockade Enhances Antigen-Specific CD4+ T Cell Responses in Humans: A New Target for Cancer Immunotherapy?
- (2009) B. Sivasankar et al. JOURNAL OF IMMUNOLOGY
- Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20(+) non-Hodgkin’s lymphoma
- (2009) Justyna Dzietczenia et al. MEDICAL ONCOLOGY
- Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti‐MUC1 antibody immune selection
- (2008) Juan Carlos Varela et al. INTERNATIONAL JOURNAL OF CANCER
- In Vitro and In Vivo Properties of Adenovirus Vectors with Increased Affinity to CD46
- (2008) H. Wang et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More